Truist Financial
IGC icon

Truist Financial’s IGC Pharma IGC Stock Holding History

Truist Financial’s Portfolio IGC Stock Details IGC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$13.2K Buy
48,667
+12,000
+33% +$3.55K ﹤0.01% 2909
2026
Q1 		$9.64K Hold
36,667
– – ﹤0.01% 2786
2025
Q4 		$10.3K Hold
36,667
– – ﹤0.01% 2756
2025
Q3 		$15.3K Hold
36,667
– – ﹤0.01% 2703
2025
Q2 		$11.2K Hold
36,667
– – ﹤0.01% 2585
2025
Q1 		$10.4K Hold
36,667
– – ﹤0.01% 2533
2024
Q4 		$12.3K Hold
36,667
– – ﹤0.01% 2501
2024
Q3 		$15.7K Hold
36,667
– – ﹤0.01% 2477
2024
Q2 		$15.9K Hold
36,667
– – ﹤0.01% 2628
2024
Q1 		$14.7K Hold
36,667
– – ﹤0.01% 2603
2023
Q4 		$10.3K Hold
36,667
– – ﹤0.01% 2621
2023
Q3 		$13.2K Hold
36,667
– – ﹤0.01% 2568
2023
Q2 		$11.4K Hold
36,667
– – ﹤0.01% 2550
2023
Q1 		$12.4K Hold
36,667
– – ﹤0.01% 2553
2022
Q4 		$11.7K Hold
36,667
– – ﹤0.01% 2538
2022
Q3 		$16K Hold
36,667
– – ﹤0.01% 2489
2022
Q2 		$19K Hold
36,667
– – ﹤0.01% 2604
2022
Q1 		$35K Hold
36,667
– – ﹤0.01% 2640
2021
Q4 		$36K Sell
36,667
-4,926
-12% -$6.61K ﹤0.01% 2712
2021
Q3 		$61K Hold
41,593
– – ﹤0.01% 2659
2021
Q2 		$68K Hold
41,593
– – ﹤0.01% 2663
2021
Q1 		$75K Buy
41,593
+4,926
+13% +$8.95K ﹤0.01% 2585
2020
Q4 		$57K Hold
36,667
– – ﹤0.01% 2501
2020
Q3 		$38K Hold
36,667
– – ﹤0.01% 2401
2020
Q2 		$22K Hold
36,667
– – ﹤0.01% 2362
2020
Q1 		$18K Hold
36,667
– – ﹤0.01% 2333
2019
Q4 		$23K Buy
+36,667
New +$30K ﹤0.01% 2459

Other funds holding IGC

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
LC
Lawood & Co Williamsport, Pennsylvania $148M AUM

Truist Financial's IGC Position: Q2 2026 in Review

Truist Financial increased its IGC Pharma (IGC) stake by 33% in Q2 2026, buying an estimated $3.55K and bringing the position to 48,667 shares worth $13.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2909.

Truist Financial first reported a position in IGC in Q4 2019 and has held it in 27 quarters since. The position peaked at $75K in Q1 2021. 36 funds tracked by Wall St. Rank hold IGC as of Q2 2026.

  • Truist Financial held 48,667 shares of IGC Pharma worth $13.2K as of Q2 2026.
  • Truist Financial bought 12,000 IGC Pharma shares in Q2 2026, an estimated $3.55K.
  • IGC Pharma made up ﹤0.01% of Truist Financial's portfolio in Q2 2026, its #2909 holding.
  • Truist Financial first reported a position in IGC Pharma in Q4 2019 and has held it in 27 quarters since.
  • Truist Financial's IGC Pharma position peaked at $75K in Q1 2021.
  • 36 funds tracked by Wall St. Rank held IGC Pharma as of Q2 2026.

Based on Truist Financial's 13F filing for Q2 2026, filed 28 Jul 2026.